Literature DB >> 35802159

Prevalence and Risk Factors of Mortality in Emphysematous Pyelonephritis Patients: A Meta-Analysis.

Xuan Thai Ngo1,2, Tuan Thanh Nguyen1,2, Ryan W Dobbs3, Minh Sam Thai1,2, Duc Huy Vu2, Le Quy Van Dinh2, Khoa Quy1, Hieu Trong Le1, Tien-Dat Hoang1, Hanh Thi Tuyet Ngo1, Trinh Ngoc Khanh Van1, Ho Yee Tiong4, Huy Gia Vuong5.   

Abstract

BACKGROUND: Emphysematous pyelonephritis (EP) is a severe necrotizing infection of the renal parenchyma which is associated with significant case mortality. We sought to identify the incidence and predictive risk factors associated with EP mortality.
METHODS: Two electronic databases, PubMed and Web of Science, were searched from their inception until June 06, 2021 for relevant articles. Two independent teams reviewed abstracts and extracted data from the selected manuscripts. A meta-analysis has been reported in line with PRISMA 2020 and AMSTAR Guidelines.
RESULTS: Of the 1080 retrieved abstracts, 79 underwent full-text review and 45 studies were included in the final analysis, comprising a total cohort of 1303 patients and 177 mortalities. The pooled prevalence of mortality among the patients with EP disease was 13%. Our analysis found a significantly decreasing trend in mortality rates, an increasing trend in minimally invasive intervention and decreasing trends in emergency nephrectomy in the EP studies from 1985 to 2020. Significant risk factors that were associated with a negative impact on survival of EP patients included sepsis (OR = 15.99), shock (OR = 15.57), disturbance of consciousness (OR = 12.11), thrombocytopenia (OR 7.85), acute renal failure (OR = 5.41), Wan classification I (OR = 4.57), emergency nephrectomy (OR = 3.73), Huang-Tseng classification III-IV (OR = 2.4) and medical management alone (OR = 2.04). Female sex (OR = 0.52) and minimally invasive intervention (OR = 0.47) (percutaneous nephrostomy or ureteral stent placement) were associated with decreased mortality rates.
CONCLUSIONS: Our study results demonstrated several significant risk factors that could help guide treatment to reduce the mortality risk of EP patients. Clinically, early treatment with a combination of minimally invasive intervention and appropriate medical management may be protective for reducing mortality risk in EP patients.
© 2022. The Author(s) under exclusive licence to Société Internationale de Chirurgie.

Entities:  

Mesh:

Year:  2022        PMID: 35802159     DOI: 10.1007/s00268-022-06647-1

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.282


  57 in total

1.  Could platelet to leucocytic count ratio (PLR) predict sepsis and clinical outcomes in patients with emphysematous pyelonephritis?

Authors:  M A Elbaset; Mohamad H Zahran; Abdelwahab Hashem; Fady K Ghobrial; Eman Elrefaie; Mohamed Badawy; Ahmed A Shokeir; Mohamed Abdelbaset Ibrahim
Journal:  J Infect Chemother       Date:  2019-05-15       Impact factor: 2.211

2.  Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis.

Authors:  J J Huang; C C Tseng
Journal:  Arch Intern Med       Date:  2000-03-27

3.  Emphysematous pyelonephritis: a 15-year experience with 20 cases.

Authors:  A A Shokeir; M El-Azab; T Mohsen; T El-Diasty
Journal:  Urology       Date:  1997-03       Impact factor: 2.649

4.  Renal emphysema in diabetic patients: CT evaluation.

Authors:  Ioannis Tsitouridis; Michael Michaelides; Dimitrios Sidiropoulos; Mary Arvanity
Journal:  Diagn Interv Radiol       Date:  2009-10-19       Impact factor: 2.630

5.  Risk of SOFA Deterioration in Conservative Treatment for Emphysematous Pyelonephritis: Pitfalls of Current Trends in Therapeutics from Multicenter Clinical Experience.

Authors:  Michinobu Ozawa; Osamu Ichiyanagi; Suguru Fujita; Sei Naito; Hiroki Fukuhara; Shinta Suenaga; Satoshi Takai; Takafumi Narisawa; Noriyuki Hosoya; Tatsuya Ishii; Takuya Yamanobe; Akinori Muto; Hitoshi Suzuki; Hayato Nishida; Tomoyuki Kato; Norihiko Tsuchiya
Journal:  Curr Urol       Date:  2019-05-10

6.  Emphysematous Pyelonephritis Case Series From South India.

Authors:  Mahesh Eswarappa; Sarita Suryadevara; Manns Manohar John; Mahesh Kumar; Sujeeth Bande Reddy; Mohammed Suhail
Journal:  Kidney Int Rep       Date:  2017-12-08

7.  Emphysematous pyelonephritis: Does a standard management algorithm and a prognostic scoring model optimize patient outcomes?

Authors:  Amit Jain; Ramanitharan Manikandan; Lalgudi Narayanan Dorairajan; Sreerag Kodakkattil Sreenivasan; Sriharsha Bokka
Journal:  Urol Ann       Date:  2019 Oct-Dec

8.  Renal salvage, an achievable goal in patients with emphysematous pyelonephritis: Outcomes of an algorithmic renal preserving strategy.

Authors:  Rajeshkumar Reddy Adapala; Ranjit Shetty; P Venugopal; G G L Prabhu; Durgarao Yalla; B Unnikrishnan
Journal:  Urol Ann       Date:  2020-04-14

9.  Emphysematous pyelonephritis: Our experience with conservative management in 14 cases.

Authors:  Pramod Kumar Sharma; Ritu Sharma; Mukesh K Vijay; Punit Tiwari; Amit Goel; Anup K Kundu
Journal:  Urol Ann       Date:  2013-07

10.  Emphysematous pyelonephritis: A 10-year experience with 26 cases.

Authors:  Raiz Ahmad Misgar; Idrees Mubarik; Arshad Iqbal Wani; Mir Iftikhar Bashir; Mahroosa Ramzan; Bashir Ahmad Laway
Journal:  Indian J Endocrinol Metab       Date:  2016 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.